In the news release, “NapaJen Pharma Closes $12.4 Million Series C Financing” issued on 9-Jan-2019 by NapaJen Pharma, Inc. over PR Newswire, we are advised by the company that one of the investors’ name was incorrect. “P&D Directions Inc.” should read “P&E Directions Inc.” The full corrected release is as follows:
January 9, 2019
· 2 min read